Riskpilot← Back to searchSign inGet full accessBIOTEAM ApS
APSActiveCVR 35659374Nicoline Kochs Plads 5, 11. 6Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2013— employees
Revenue 2025
DKK -3K
-55% vs 2024
EBITDA margin
208.0%
+38% vs 2024
Equity ratio
99.8%
Financial strength
Net profit 2025
DKK 326K
-60% vs 2024
| Revenue | DKK -3K | -55% |
| EBITDA | DKK -6K | +38% |
| Net profit | DKK 326K | -60% |
| Total assets | DKK 3,6M | +5% |
| Equity | DKK 3,6M | +6% |
| Employees | — | — |
Legal name
BIOTEAM ApS
CVR number
35659374
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
23. december 2013
Share capital
DKK 80.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Company purpose
Selskabets formål er at besidde ejerandele i andre selskaber samt foretage formueanbringelser
Address
Nicoline Kochs Plads 5, 11. 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -3 | -8 | -5 | -6 | -5 | -8 | -7 | -9 | -11 | 3 | -6 | -3 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -3 | -8 | -5 | -6 | -5 | -8 | -7 | -9 | -11 | 1 | -9 | -6 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -3 | -8 | -5 | -6 | -5 | -8 | -7 | -9 | -11 | 1 | -9 | -6 |
| Net financials | 184 | 33 | 374 | 344 | 332 | 209 | 378 | 589 | 446 | 453 | 852 | 311 |
| Profit before tax | 181 | 25 | 369 | 338 | 327 | 202 | 371 | 580 | 435 | 454 | 843 | 306 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 14 | -0 | -0 | 32 | -21 |
| Net profit | 181 | 25 | 369 | 338 | 327 | 202 | 371 | 566 | 435 | 454 | 811 | 326 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 530 | 422 | 784 | 1.021 | 1.245 | 1.341 | 1.604 | 2.072 | 2.381 | 2.727 | 3.440 | 3.624 |
| Equity | 441 | 417 | 782 | 1.018 | 1.242 | 1.338 | 1.601 | 2.057 | 2.378 | 2.718 | 3.411 | 3.616 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 | 0 | 0 | 21 | 0 |
| Short-term debt | 89 | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 9 | 8 | 8 |
| Total debt | 89 | 6 | 3 | 3 | 3 | 3 | 3 | 16 | 3 | 9 | 29 | 8 |
EBITDA margin
-555400.0%
This company
15.8%
Market median
-3515290% vs market
20142025
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20142025
Return on equity
9.0%
This company
18.4%
Market median
-51% vs market
20142025
Net profit margin
32638800.0%
This company
8.1%
Market median
+402948048% vs market
20142025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20142025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20142025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BIOTEAM ApS 
BIOLAB EJENDOMSSELSKAB A/SBoard members of BIOTEAM ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|